InsiderInsights.com Daily Round Up 1/11/16: APC, PSX, SRE, XLRN

|
Includes: APC, ARRY, BH, BSX, CTIC, DRI, DXCM, GSBD, HII, LWAY, MDT, PSX, RRC, SMLP, SRE, TBIO, UTI, VLGEA, XLRN
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 1/11/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance, it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

On Today's Tables:

Insider trades were rated Significant at:

  • Acceleron Pharma (NASDAQ:XLRN);
  • Sempra Energy (NYSE:SRE);
  • Phillips 66 (NYSE:PSX), and;
  • Anadarko Petroleum Corp. (NYSE:APC).

Insider trades were rated Nearly Significant at:

  • Summit Midstream Partners (NYSE:SMLP);
  • Transgenomic, Inc. (NASDAQ:TBIO);
  • Goldman Sachs BDC (NYSE:GSBD);
  • Village Super Market (NASDAQ:VLGEA);
  • Range Resources Corp. (NYSE:RRC), and;
  • Lifeway Foods (NASDAQ:LWAY).

Insider trades were considered Insignificant at:

  • Universal Technical Institute (NYSE:UTI);
  • Biglari Holdings (NYSE:BH);
  • Array BioPharma (NASDAQ:ARRY);
  • Huntington Ingalls Industries (NYSE:HII);
  • DexCom (NASDAQ:DXCM), and;
  • Boston Scientific Corp. (NYSE:BSX).

There is a Conflicted Insider Signal (both purchases and sales) at:

  • Medtronic (NYSE:MDT);
  • Darden Restaurants (NYSE:DRI), and;
  • CTI BioPharma Corp. (NASDAQ:CTIC).

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Berkshire Hathaway BO Phillips 66 PSX B $126,127,768
2 Celgene BO Acceleron Pharma XLRN JB* $32,000,000
3 Kirk Randal J BO Transgenomic TBIO JB* $4,474,825
4 Redmile Group BO Array BioPharma ARRY B $3,394,500
5 Energy Capital II DIR,BO Summit Midstream Partners SMLP AB $2,394,659
6 Coliseum Cap BO Universal Technical Institute UTI B $1,688,850
7 BVF Partners LP BO CTI BioPharma Corp. CTIC B,JB* $1,218,715
8 Fluor Peter J DIR Anadarko Petroleum Corp. APC B $1,029,855
9 Biglari Sardar CB,CEO,BO Biglari Holdings BH AB $975,125
10 Goldman Sachs BO Goldman Sachs BDC GSBD JB* $448,915
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:
B = Open-market Buy; AB = 10b5-1 (automatic) Buy; JB* = Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Smith Jeffrey C DIR Darden Restaurants DRI S $81,247,640
2 Niland Barbara A VP,CFO Huntington Ingalls Industries HII AS $2,633,930
3 Rowland G Joyce VP Sempra Energy SRE AS $1,007,950
4 Hanson Bryan C VP,PR Medtronic MDT AS $375,000
5 Smolyansky Edward CAO,COO,TR,SEC Lifeway Foods LWAY S $337,646
6 Phalen Michael P VP,PR Boston Scientific Corp. BSX AS $322,045
7 Farquharson Alan VP Range Resources Corp. RRC S $307,790
8 Lister John VP,GC DexCom DXCM AS $293,935
9 Est of P Sumas BO Village Super Market VLGEA S $141,298
10 Pratt Timothy A VP,GC Boston Scientific Corp. BSX AS $126,549
Click to enlarge

InsiderInsights.com | Key to Insider Title and Trans Type Codes:
S = Open-market Sale; AS = 10b5-1 (automatic) Sale; JS* = Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.